Company Valuation: Augmedix, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023
Market Cap 1 117 58.39 284
Change - -50.11% 386.43%
Enterprise Value (EV) 1 90.63 54.12 263.7
Change - -40.29% 387.23%
P/E -5.1x -2.39x -13.4x
PBR 4.97x 39.8x 12.2x
PEG 0.1x -0.41x 0.4x
Capitalization / Revenue 5.28x 1.89x 6.33x
EV / Revenue 4.09x 1.75x 5.88x
EV / EBITDA -5.25x -2.52x -14.9x
EV / EBIT -5.05x -2.42x -14x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -0.6174 -0.6534 -0.4362
Distribution rate - - -
Net sales 1 22.16 30.93 44.86
EBITDA 1 -17.25 -21.52 -17.68
EBIT 1 -17.94 -22.37 -18.78
Net income 1 -17.85 -24.45 -19.17
Net Debt 1 -26.42 -4.277 -20.37
Reference price 2 3.150 1.560 5.850
Nbr of stocks (in thousands) 37,158 37,432 48,555
Announcement Date 3/30/22 4/17/23 3/26/24
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 116M
29.7x15.13x21.51x0.73% 683B
35.77x6.55x23.27x1.01% 78.78B
-104.14x23.58x56.71x-.--% 65B
22.54x4.45x9.79x0.75% 64.57B
10.8x1.44x7.39x1.02% 47.01B
46.23x1.71x9.55x-.--% 45.99B
19.09x3.28x7.82x1.66% 30.64B
20.21x6.16x11.85x-.--% 26.42B
9.55x2.55x6.15x-.--% 24.09B
Average 9.97x 7.21x 17.12x 0.57% 106.57B
Weighted average by Cap. 20.43x 12.34x 20.96x 0.68%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Augmedix, Inc.

Historical PBR trend

Valuation ratios - PBR - Augmedix, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Augmedix, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Augmedix, Inc.

  1. Stock Market
  2. Stocks
  3. AUGX Stock
  4. Valuation Augmedix, Inc.